By jdubble07
(2016-08-24)Heather Bresch is a pharmaceutical executive who is currently the Chief Executive Officer of Mylan.
Somewhat controversially, while increasing the emergency-use EpiPen, used to treat anaphylaxis from $56 to $317, Bresch's salary increased from $2M to $19M.